Skip to main content
. 2020 May 19;35(3):165–178. doi: 10.1093/her/cyaa010

Table II.

Latinx GBMSM and TW in the HOLA intervention and the waitlist control groups at baseline and 12-month follow-up

Variable Unadjusted rates/means
Baseline (%)
Follow-up (%)
Intervention Waitlist P-value Intervention Waitlist P-value AOR or adjusted beta (95% CI), P-valuea
HIV testing 58.1 55.0 0.7 90.2 60.0 <0.001 8.3 (3.0 to 23.0), <0.0001
Past 3-month condom use 34.9 25.0 0.2 63.4 50.7 0.2 1.6 (0.6 to 3.8), 0.3
HIV knowledge 8.5 8.2 0.5 11.1 8.8 <0.001 2.2 (1.7 to 2.7), <0.0001
STI knowledge 4.9 5.6 0.1 9.4 6.2 <0.001 3.3 (2.5 to 4.1), <0.001
Condom skills 14.3 14.5 0.5 17.2 15.0 0.0002 2.0 (1.2 to 2.7), <0.0001
Condom efficacy 4.4 4.3 0.7 4.7 4.4 0.1 6.7 (2.9 to 10.6), 0.0008
Condom expectancy 3.0 3.1 0.7 3.0 3.0 0.9 0.5 (−3.0 to 4.1), 0.8
Sexual communication 2.4 2.6 0.6 3.0 2.6 0.1 0.5 (−0.1 to 1.1), 0.09
Masculinity 52.5 52.5 0.9 52.2 54.0 0.3 −1.1 (−3.8 to 1.5), 0.4
Homo−negativity 36.2 36.1 0.9 39.3 38.4 0.5 0.8 (−2.6 to 4.2), 0.7
Fatalism 43.6 44.5 0.7 42.9 46.8 0.1 −3.6 (−7.6 to 0.5), 0.09
Attachment 4.1 3.7 0.2 4.2 4.1 0.8 −0.6 (−1.8 to 0.5), 0.3
Social support 3.1 3.0 0.4 3.1 3.0 0.6 0.2 (−6.3 to 6.7), 0.95
a

AORs were based on multivariable random-effect logistic regression models accounting for social network clustering, baseline rates, educational attainment and country of origin.

Bold values are significant at P <0.05